Rocaglamide (RocA), a small molecule compound, activates the cGAS-STING signaling pathway and promotes the infiltration and antitumor activity of natural killer (NK) cells in NSCLC (Yan et al., 2022). The gene discussed is STING1; the disease is non-small cell lung carcinoma.